Notice: Trying to access array offset on value of type null in /srv/pobeda.altspu.ru/wp-content/plugins/wp-recall/functions/frontend.php on line 698
Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM (October 1998). «p300/MDM2 complexes participate in MDM2-mediated p53 degradation». Marmorstein LY, Ouchi T, Aaronson SA (November 1998). «The BRCA2 gene product or service functionally interacts with p53 and RAD51». Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E, Yao TP (November 2002). «MDM2-HDAC1-mediated deacetylation of p53 is demanded for its degradation». Chang NS (March 2002). «The non-ankyrin C terminus of Ikappa Balpha physically interacts with p53 in vivo and dissociates in reaction to apoptotic strain, hypoxia, DNA injury, and transforming growth factor-beta 1-mediated growth suppression». Yan C, Wang H, Boyd DD (March 2002). «ATF3 represses 72-kDa form IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter». Lin J, Yang Q, Yan Z, Markowitz J, Wilder PT, Carrier F, Weber DJ (August 2004). «Inhibiting S100B restores p53 degrees in primary malignant melanoma cancer cells».
Lin Y, Khokhlatchev A, Figeys D, Avruch J (December 2002). «Death-connected protein 4 binds MST1 and augments MST1-induced apoptosis». Kondo S, Lu Y, Debbas M, Lin AW, Sarosi I, Itie A, Wakeham A, Tuan J, Saris C, Elliott G, Ma W, Benchimol S, Lowe SW, Mak TW, Thukral SK (April 2003). «Characterization of cells and gene-qualified mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1)». Cuddihy AR, Wong AH, Tam NW, Li S, Koromilas AE (April 1999). «The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro». Chen D, Li M, Luo J, Gu W (April 2003). «Direct interactions involving HIF-1 alpha and Mdm2 modulate p53 function». Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R (November 2003). «Regulation of BRCC, a holoenzyme sophisticated that contains BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA maintenance».
Minty A, Dumont X, Kaghad M, Caput D (November 2000). «Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif». Li L, Ljungman M, Dixon JE (January 2000). «The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53». Young PJ, Day PM, Zhou J, Androphy EJ, Morris GE, Lorson CL (January 2002). «A direct interaction amongst the survival motor neuron protein and p53 and its marriage to spinal muscular atrophy». Chai YL, Cui J, Shao N, Shyam E, Reddy P, free-sex-Rooms Rao VN (January 1999). «The next BRCT area of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter». Taniura H, Matsumoto K, Yoshikawa K (June 1999). «Physical and useful interactions of neuronal growth suppressor necdin with p53». Gallagher WM, Argentini M, Sierra V, Bracco L, Debussche L, Conseiller E (June 1999). «MBP1: a novel mutant p53-unique protein partner with oncogenic properties». Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV, Jope RS (June 2002). «Direct, activating interaction in between glycogen synthase kinase-3beta and p53 just after DNA problems». Ko LJ, Shieh SY, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C, Pan ZQ (December 1997). «p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent fashion».
Drané P, Barel M, Balbo M, Frade R (December 1997). «Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional homes with p53». Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T (December 1992). «Wild-form p53 binds to the TATA-binding protein and represses transcription». Shvarts A, Bazuine M, Dekker P, Ramos YF, Steegenga WT, Merckx G, van Ham RC, van der Houven van Oordt W, van der Eb AJ, Jochemsen AG (July 1997). «Isolation and identification of the human homolog of a new p53-binding protein, Mdmx» (PDF). Buchhop S, Gibson MK, Wang XW, Wagner P, Stürzbecher HW, Harris CC (October 1997). «Interaction of p53 with the human Rad51 protein». Westphal CH, Schmaltz C, Rowan S, Elson A, Fisher DE, Leder P (May 1997). «Genetic interactions amongst atm and p53 affect mobile proliferation and irradiation-induced mobile cycle checkpoints». Yu A, Fan HY, Liao D, Bailey Ad, Weiner AM (May 2000). «Activation of p53 or loss of the Cockayne syndrome group B restore protein will cause metaphase fragility of human U1, U2, and 5S genes». Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale Ad, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X, Wu H (February 2003). «PTEN tumor suppressor regulates p53 protein degrees and exercise by way of phosphatase-dependent and -unbiased mechanisms».